MDNA
Closed
Medicenna Therapeutics corp
0.3057
-0.0093 (-2.95%)
Last Update: 03 Jan 2024 17:30:00
Yesterday: 0.315
Day's Range: 0.303 - 0.3105
Send
sign up or login to leave a comment!
When Written:
0.5834
Medicenna Therapeutics Corp is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of cancer and other diseases. The company's lead product candidate, MDNA55, is a targeted immunotherapy that is designed to treat glioblastoma, a type of brain cancer. The company is also developing other targeted therapies for various types of cancer, including ovarian cancer and leukemia.
Medicenna Therapeutics Corp was founded in 2010 and is headquartered in Toronto, Canada. The company is publicly traded on the Toronto Stock Exchange under the symbol MDNA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Medicenna Therapeutics Corp was founded in 2010 and is headquartered in Toronto, Canada. The company is publicly traded on the Toronto Stock Exchange under the symbol MDNA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








